{"id":"AGY-FED-HEALTH-OTHER-016","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","authority":"21 U.S.C. 822(e); 21 C.F.R. 1301.12; 21 C.F.R. 1307.03","instrument":"DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration","title":"Off-site OTP delivery method (Final)","dateIssued":"2020-04-07","effective":"2020-04-07","end":"During the public health emergency or until withdrawn or modified by DEA","startDate":"2020-04-07","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"addressees":["DEA-registered narcotic treatment programs"],"clause":"DEA, following consultation with SAMHSA, is issuing this letter to provide OTPs with greater flexibility in how they deliver take-home doses of methadone to their patients. DEA is doing so by temporarily allowing OTPs to repeatedly use the same off-site location to deliver take-home methadone doses to their patients without separately registering that location with DEA, subject to certain conditions.","enforcement":"Registration requirements under 21 U.S.C. 822(e) and 842","functions":["CL clinical dispensing","TR transport","CB patients"],"notes":"Opioid treatment programs restructured dosing around distancing and quarantine.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-025)(DEA078)_Off-site_OTP_delivery_method_(Final)+_esign.pdf","snapshot":"","fileExists":true,"fileBytes":214809,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-016","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-016","citation":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration (Apr. 7, 2020) (Ex. AGY-FED-HEALTH-OTHER-016)","stateName":"","related":["AGY-FED-HEALTH-OTHER-014","AGY-FED-HEALTH-OTHER-011","AGY-FED-HEALTH-OTHER-020","AGY-FED-HEALTH-OTHER-010"]}